Adridox 50 mg Injection 1's Substitute
United Biotech Pvt Ltd
₹951.5
(₹38.06/ 1ml)
Adley Formulations
₹1000
(₹40.0/ 1ml)
Biochem Pharmaceutical Industries Ltd
₹311
(₹311.0 per unit)
Celon Laboratories Pvt Ltd
₹9460
(₹378.4/ 1ml)
Neon Laboratories Ltd
₹398
(₹398.0 per unit)
Intas Pharmaceuticals Ltd
₹10406
(₹416.24/ 1ml)
Sun Pharmaceutical Industries Ltd
₹14235
(₹569.4/ 1ml)
Zydus Cadila
₹14493
(₹579.72/ 1ml)
United Biotech Pvt Ltd
₹19230
(₹769.2/ 1ml)
Fresenius Kabi Oncology Ltd
₹20189.8
(₹807.59/ 1ml)
Intas Pharmaceuticals Ltd
₹833
(₹833.0 per unit)
Hetero Healthcare Pvt Ltd
₹845.5
(₹845.5 per unit)
Pfizer Ltd
₹847.5
(₹847.5 per unit)
Orca Healthcare Pvt Ltd
₹900
(₹900.0 per unit)
Celon Laboratories Pvt Ltd
₹1103
(₹1103.0 per unit)

Patients may explore substitutes in the following scenarios:
Before you switch from Adridox 50 mg Injection 1's to another medicine, here are some important points to keep in mind:
Most substitutes contain the same active ingredient - DOXORUBICIN-50MG, but the fillers, coating, or manufacturing quality may vary slightly.
Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.
Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.
A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.
Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.
Adridox 50 mg Injection 1's is used to treat various types of cancer. The detailed uses of Adridox 50 mg Injection 1's are as follows:
Adridox 50 mg Injection 1's contains Doxorubicin, which belongs to the class of anthracycline topoisomerase inhibitors. It inhibits the topoisomerase II enzyme by intercalating the DNA base pairs. This causes double helix DNA to be uncoiled, thereby destroying the DNA and RNA synthesis. Adridox 50 mg Injection 1's is also used in the treatment of acute lymphoblastic leukaemia, acute myeloblastic leukaemia, Hodgkin lymphoma, Non-Hodgkin lymphoma, metastatic breast cancer, metastatic Wilms’ tumour, metastatic neuroblastoma, metastatic soft tissue sarcoma, metastatic bone sarcomas, metastatic ovarian carcinoma, metastatic transitional cell bladder carcinoma, metastatic thyroid carcinoma, metastatic gastric carcinoma, metastatic bronchogenic carcinoma.
RX
RX
RX
RX